Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019).
D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006321:Heart / Q000187:drug effects; D006801:Humans; D007279:Injections, Subcutaneous; D009921:Metaproterenol / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D012118:Resorcinols / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects*; D013268:Stimulation, Chemical
D001993:Bronchodilator Agents; D010627:Phenethylamines; D010919:Placebos; D012118:Resorcinols; D009921:Metaproterenol